Walgreen Company Second Quarter Earnings Call
25th March 2008 00:00 AM |
|
| Profit rose to $685.9 million, helped by cost-cutting and an extra day in the quarter because of leap year. |
|
| Walgreen announced a deal with a pharmacy benefits management company, Prime Therapeutics that expands its business as a provider of specialty pharmacy services. General merchandise sales improved, boosted by strong Valentine''s Day business, after weaker-than-expected Christmas results. Sales at stores open at least a year rose 4.7%, with prescription same-store sales up 5.2%.Walgreen announced plans to acquire I-trax Inc. |
|
|
Full Story... |
Walgreen First Quarter Earnings Call
27th December 2007 00:00 AM |
|
| Profit increased to $455.5 million, helped by higher sales and cost controls. |
|
| The U.S. drugstore operator’s revenue increased 10.4% to $14.03 billion, failing to meet analysts’ expectations of $14.11 billion. Same-store sales rose 5.4%, while front-end same-drugstore sales rose 4.6%. Prescription sales, which accounted for 66.1% of sales, climbed 11.1%. Prescription sales in comparable stores rose 5.9%, while the number of prescriptions filled in comparable stores increased 3.7%. The company plans to open 550 new stores in 2007, with a net increase of more than 475. |
|
|
Full Story... |
Walgreen Fourth Quarter Earnings Call
2nd October 2007 00:00 AM |
|
| Profit was $396.5 million, or 40 cents a share, compared with $412.3 million, or 41 cents a share, a year ago. |
|
| The management said its fourth-quarter profit declined 4% hurt by an 11% higher costs and the weaker profit margin from selling certain generic drugs. Same-store sales increased 6.3%, while front-end same-drugstore sales climbed 6.1% in the latest quarter. Walgreen expects more than $2 billion in capital investments for fiscal year 2008. |
|
|
Full Story... |
Walgreen Third Quarter Earnings Call
18th September 2007 00:00 AM |
|
| Profit for the quarter was $561.2 million, or 56 cents per share versus $469.2 million, or 46 cents per share a year ago. |
|
| Stronger prescription sales drove the nation''s biggest pharmacy chain third-quarter profit 20% higher than a year ago. Revenue increased 13% to $13.7 billion from $12.2 billion last year. Prescription sales, which accounted for 65.9% of total sales, climbed 13.8%. The results included at least $17 million in one-time credits but the management didn''t break out the earnings-per-share impact of the gains. Same-store sales jumped 7.8% and non-pharmacy same-store sales grew 5.6%. |
|
|
Full Story... |
|
|
